Impact BioMedical
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $7 | $7 | $18 | $7 |
Gross Profit | -278 | -415 | 17 | -4 |
EBITDA | -2,004 | 2,941 | -925 | -13,804 |
EBIT | -2,289 | 2,655 | -1,213 | -14,092 |
Net Income | -2,287 | 5,245 | -1,470 | -14,346 |
Net Change In Cash | 7 | 7 | 18 | 7 |
Free Cash Flow | -464 | 99 | -613 | -694 |
Cash | 20 | 3 | 12 | 624 |
Basic Shares | 107,785 | 31,550 | 12,185 | 12,185 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $32 | $1,619 | $1,029 | $50 |
Gross Profit | -392 | 1,619 | -1,120 | -1,113 |
EBITDA | -12,512 | -1,069 | -2,843 | -2,341 |
EBIT | -13,657 | -1,308 | -3,963 | -3,454 |
Net Income | -11,838 | -1,425 | -4,336 | -7,051 |
Net Change In Cash | 32 | 1,619 | 1,029 | 50 |
Free Cash Flow | -1,890 | -5,635 | -2,869 | -2,518 |
Cash | 3 | 1,999 | 1 | 2 |
Basic Shares | 31,550 | 41,754 | 60,248 | 11,497 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.02 |
2025-12-31 | $0.05 |
2025-09-30 | -$0.12 |
2025-06-30 | -$1.18 |